Mirum Pharmaceuticals, Inc. MIRM Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $261.46M+43.5% | $254.38M+25.3% | $230.14M+17.5% | $188.37M-9.7% | $182.26M-35.3% | ||
| $61.35M-6.8% | $86.64M— | $93.53M— | $76.43M— | $65.85M— | ||
| $133.11M+38.9% | $123.33M+57.5% | $107.13M+56.3% | $106.84M+76.8% | $95.85M+74.3% | ||
| $97.37M+12.1% | $94.27M+9.6% | $91.78M+6.8% | $89.36M+3.2% | $86.85M+16.3% | ||
| $569.44M+38.6% | $549.68M+39.9% | $530.58M+37.2% | $453.4M+23.3% | $410.82M+5.5% | ||
| $2.41M+118% | $1.86M+63.5% | $1.28M+5.4% | $1.18M+6.9% | $1.11M+121% | ||
| $254.15M+4.2% | $260.92M+4.4% | $231.9M-9.3% | $237.87M-9.1% | $243.85M-5.3% | ||
| $890.92M+29.1% | $842.81M+25.7% | $785.12M+17.6% | $725.83M+9.8% | $690.25M+5.9% | ||
| $59.4M+410% | $9.61M-34.2% | $12.17M+27.5% | $17.66M+79.4% | $11.64M-27.2% | ||
| $272.82M+114% | $205.8M+62.6% | $160.36M+38.5% | $144.8M+28.9% | $127.58M+20.5% | ||
| $648.42M+41.9% | $528.12M+18.6% | $493.07M+13.1% | $470.67M+9.0% | $456.99M+9.5% | ||
| 200M0.0% | 200M+3,999,900% | 200M0.0% | 200M0.0% | 200M0.0% | ||
| -$1.46B-121% | -$667.54M-3.6% | -$661.81M-6.7% | -$664.72M-9.7% | -$658.86M-13.3% | ||
| $242.49M+4.0% | $314.69M+39.5% | $292.05M+25.9% | $255.16M+11.4% | $233.26M-0.6% | ||
| $890.92M+29.1% | $842.81M+25.7% | $785.12M+17.6% | $725.83M+9.8% | $690.25M+5.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Mirum Pharmaceuticals, Inc.'s total assets?
- Mirum Pharmaceuticals, Inc. (MIRM) holds $890.9M in total assets, up 29.1% year over year.
- How much debt does Mirum Pharmaceuticals, Inc. have?
- Mirum Pharmaceuticals, Inc. carries $13.5M in total debt against $242.5M of shareholders' equity, a debt-to-equity ratio of 0.06.
- How much cash does Mirum Pharmaceuticals, Inc. have?
- Mirum Pharmaceuticals, Inc. holds $261.5M in cash and equivalents.
- Can Mirum Pharmaceuticals, Inc. cover its short-term obligations?
- Its current ratio is 2.09 — current assets exceed current liabilities.
- Where does Mirum Pharmaceuticals, Inc.'s balance sheet data come from?
- Every line is extracted from Mirum Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
